Gil Morgan, MD(@weoncologists) 's Twitter Profileg
Gil Morgan, MD

@weoncologists

Clinical Oncologist from Texas🇺🇸Director of @OncoAlert 🚨 Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own🌏

ID:39742016

calendar_today13-05-2009 12:44:05

18,2K Tweets

16,3K Followers

7,7K Following

Follow People
Daniela Shveid Gerson(@DSG_MD) 's Twitter Profile Photo

Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial. Delivered at 1000 times the dose rate of conventional-dose-rate photon radiotherapy 👀 OncoAlert jamanetwork.com/journals/jamao…

account_circle
Petros Grivas(@PGrivasMDPhD) 's Twitter Profile Photo

It was fantastic to see you Gil Morgan OncoAlert and spend amazing time in Athens with Giuseppe Banna Jarushka Naidoo Marita Lykka MD Marinos Tsiatas & others! Thanks Giannis Mountzios for the invitation & great hospitality! ΕΟΠΕ is doing great work in Greece! Hope for more meetings in Athens!

It was fantastic to see you @weoncologists @OncoAlert and spend amazing time in Athens with @gbanna74 @DrJNaidoo @marilykmd @mtsiatas & others! Thanks @g_mountzios for the invitation & great hospitality! @HeSMOtweet is doing great work in Greece! Hope for more meetings in Athens!
account_circle
Shankar Siva(@_ShankarSiva) 's Twitter Profile Photo

Ryan Hughes at presidential: a nice framework for thinking about toxicity/QoL assessment ⬇️. Did you know in an EORTC review of >200 trials, >60% had significant differences in PROs, ~75% of which were in global domains? ➡️ bit.ly/3gAldBr - OncoAlert

@hughrt7 at presidential: a nice framework for thinking about toxicity/QoL assessment ⬇️. Did you know in an EORTC review of >200 trials, >60% had significant differences in PROs, ~75% of which were in global domains? ➡️ bit.ly/3gAldBr - #ASTRO2022 #radonc @OncoAlert
account_circle
Henning Willers, MD (he/him/his)(@HenningWillers) 's Twitter Profile Photo

Carmen Bergom MD PhD on cardiac radiation toxicity and sparing

No question the importance of it. We are moving towards contouring heart substructure and then imposing dose volume constraints. ALARA is an important principle here but it's not sufficient🤔


OncoAlert

@carmenbergom on cardiac radiation toxicity and sparing No question the importance of it. We are moving towards contouring heart substructure and then imposing dose volume constraints. ALARA is an important principle here but it's not sufficient🤔 #ASTRO22 @OncoAlert
account_circle
Henning Willers, MD (he/him/his)(@HenningWillers) 's Twitter Profile Photo

1/

Presidential Symposium on normal tissue toxicity⚠️

Great intro by Sarah Kerns🙏

There is some evidence for genetic predisposition to unusual normal tissue toxicity but outside perhaps ATM how to predict?

It's complex...



OncoAlert

1/ Presidential Symposium on normal tissue toxicity⚠️ Great intro by Sarah Kerns🙏 There is some evidence for genetic predisposition to unusual normal tissue toxicity but outside perhaps ATM how to predict? It's complex... #ASTRO22 #radbio @OncoAlert
account_circle
Shankar Siva(@_ShankarSiva) 's Twitter Profile Photo

Erin Gillespie, MD presents a provocative phase II RCT of prophylactic to asymptomatic but high risk bone Mets. N=93 Convincing home run, 29% vs 1.6% skeletal related events, with an ⬆️ OS benefit! Remained significant on MVA

@ErinGillespieMD presents a provocative phase II RCT of prophylactic #radiotherapy to asymptomatic but high risk bone Mets. N=93 Convincing home run, 29% vs 1.6% skeletal related events, with an ⬆️ OS benefit! Remained significant on MVA #ASTRO22 #OncoAlert
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Dear friends at
On behalf of the OncoAlert 🚨network, Our heartfelt congratulations to the ASTRO abstract award winners🏆 ‼️

Kudos🙌

Dear friends at #ASTRO22 On behalf of the @OncoAlert 🚨network, Our heartfelt congratulations to the @ASTRO_org abstract award winners🏆 ‼️ Kudos🙌
account_circle
Nat Lester-C🎃ll, MD(@DrLesterColl) 's Twitter Profile Photo

Kicking off the clinical trials session with Chelsea C Pinnix MD PhD presenting ph II study of response adaptive low dose RT for orbital lymphoma

✅90% CR, limited toxicity!

OncoAlert

Kicking off the clinical trials session with @ChelseaPinnix presenting ph II study of response adaptive low dose RT for orbital lymphoma ✅90% CR, limited toxicity! #ASTRO22 #lycsm @OncoAlert
account_circle
Nat Lester-C🎃ll, MD(@DrLesterColl) 's Twitter Profile Photo

Clinical Trials #2

Dr. Tamim Niazi showing that moderate hypofrac (68/25) for high risk is similar to low/int risk populations OncoAlert

↔️ similar cancer outcomes - 7 yr OS, PCSM, BFFS, DMFS
⬆️ acute GU/GI tox, with no differences in late effects

#ASTRO22 Clinical Trials #2 @niazi_Dr7 showing that moderate hypofrac (68/25) for high risk #prostatecancer is similar to low/int risk populations #pcsm @OncoAlert ↔️ similar cancer outcomes - 7 yr OS, PCSM, BFFS, DMFS ⬆️ acute GU/GI tox, with no differences in late effects
account_circle
Gil Morgan, MD(@weoncologists) 's Twitter Profile Photo

My heartfelt thanks to the Athenian Oncology Congress for the invitation and to the Hellenic Society for Medical Oncology ΕΟΠΕ for the tremendous partnership with OncoAlert 🚨
My deepest of gratitude goes to my friend Giannis Mountzios
Thank you Athens🇬🇷

My heartfelt thanks to the Athenian Oncology Congress for the invitation and to the Hellenic Society for Medical Oncology @HeSMOtweet for the tremendous partnership with @OncoAlert 🚨 My deepest of gratitude goes to my friend @g_mountzios Thank you Athens🇬🇷
account_circle
ASTRO(@ASTRO_org) 's Twitter Profile Photo

Today is the day! Official start of ! Join us at 9:15 for the official welcome from Shilpen Patel.
Virtual attendees log in early to make sure you’re all set! OncoAlert

Today is the day! Official start of #ASTRO22! Join us at 9:15 for the official welcome from @PatelShilpen. Virtual attendees log in early to make sure you’re all set! #radonc #medphys #radbio @OncoAlert
account_circle